The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes with statins and CDK4/6 inhibitors in patients with metastatic HR+/HER2- breast cancer.
 
Tyler Kristoff
Patents, Royalties, Other Intellectual Property - Catheter Retention Device: US20240181218A1
 
Sydney Habert
No Relationships to Disclose
 
Sumaiya Alam
No Relationships to Disclose
 
Leo Liu
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Kevin Kalinsky
Employment - EQRx (I)
Stock and Other Ownership Interests - EQRx (I)
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Cullinan Oncology; Daiichi Sankyo/Astra Zeneca; eFFECTOR Therapeutics; Genentech/Roche; Gilead Sciences; Lilly; Menarini Silicon Biosystems; Merck; mersana; Mersana; Myovant Sciences; Novartis; Pfizer; Prelude Therapeutics; ProteinQure; Puma Biotechnology; RayzeBio; Regor; Relay Therapeutics; Takeda
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Daichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Seagen (Inst)
 
Ruth Sacks
Stock and Other Ownership Interests - Quest Diagnostics
Honoraria - DDHO conference; GA ASCO; ONC LIVE
Research Funding - Gilead Sciences